Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas

(2015) Hua Gao et al.   BMC CANCER

GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment

(2014) Dongwei Dai et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Hormone Secretion by Pituitary Adenomas Is Characterized by Increased Disorderliness and Spikiness but More Regular Pulsing

(2014) Ferdinand Roelfsema et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

(2013) Jacqueline Trouillas et al.   ACTA NEUROPATHOLOGICA

Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene

(2013) Albert Beckers et al.   ENDOCRINE REVIEWS

Epithelial Splicing Regulator Protein 1 and Alternative Splicing in Somatotroph Adenomas

(2013) Tove Lekva et al.   ENDOCRINOLOGY

Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior

(2013) Alberto Righi et al.   HUMAN PATHOLOGY

Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas

(2013) Fei Wang et al.   JOURNAL OF NEURO-ONCOLOGY

Aggressive tumors and difficult choices in acromegaly

(2013) Carmen A. Carrasco et al.   Pituitary

Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery

(2013) Tove Lekva et al.   PLoS One

Ultrasound Increases Nanoparticle Delivery by Reducing Intratumoral Pressure and Increasing Transport in Epithelial and Epithelial-Mesenchymal Transition Tumors

(2012) K. D. Watson et al.   CANCER RESEARCH

Anterior pituitary cell networks

(2012) P.R. Le Tissier et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with Acromegaly

(2012) Tove Lekva et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Biomarkers of aggressive pituitary adenomas

(2012) Ozgur Mete et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Novel pathway for somatostatin analogs in patients with acromegaly

(2012) Mônica R. Gadelha et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours

(2011) Johan Arild Evang et al.   CLINICAL ENDOCRINOLOGY

Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly

(2011) Stine Lyngvi Fougner et al.   CLINICAL ENDOCRINOLOGY

Expression of somatostatin receptors, dopamine D2 receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas

(2011) A. Saveanu et al.   ENDOCRINE-RELATED CANCER

In Nonfunctional Pituitary Adenomas, Estrogen Receptors and Slug Contribute to Development of Invasiveness

(2011) Wei Zhou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pathogenesis of pituitary tumors

(2011) Shlomo Melmed   Nature Reviews Endocrinology

The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response

(2010) Stine Lyngvi Fougner et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Identification and consequences of galectin-3 expression in pituitary tumors

(2010) A. Righi et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Proliferation markers of human pituitary tumors: Contribution of a genome-wide transcriptome approach

(2010) Anne Wierinckx et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The Pathogenesis of Pituitary Tumors

(2009) Sylvia L. Asa et al.   Annual Review of Pathology-Mechanisms of Disease

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Characterization of adherens junction protein expression and localization in pituitary cell networks

(2009) Norbert Chauvet et al.   JOURNAL OF ENDOCRINOLOGY

Involvement of Members of the Cadherin Superfamily in Cancer

(2009) G. Berx et al.   Cold Spring Harbor Perspectives in Biology

Cadherin switching

(2008) M. J. Wheelock et al.   JOURNAL OF CELL SCIENCE

Cadherins and cancer: how does cadherin dysfunction promote tumor progression?

(2008) A Jeanes et al.   ONCOGENE

Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas

(2007) A. Saveanu et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY